
IHC-P analysis of human breast tissue using GTX85433 CCDC98 antibody. Working concentration : 5 microg/ml
CCDC98 antibody
GTX85433
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse
TargetABRAXAS1
Overview
- SupplierGeneTex
- Product NameCCDC98 antibody
- Delivery Days Customer9
- Antibody SpecificityThis antibody is specific for CCDC98 N-Terminus
- Application Supplier NoteWB: 1 microg/mL. IHC-P: 5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID84142
- Target nameABRAXAS1
- Target descriptionabraxas 1, BRCA1 A complex subunit
- Target synonymsABRA1; abraxas protein; BRCA1-A complex subunit Abraxas 1; CCDC98; coiled-coil domain containing 98; FAM175A; family with sequence similarity 175 member A
- HostRabbit
- IsotypeIgG
- Protein IDQ6UWZ7
- Protein NameBRCA1-A complex subunit Abraxas 1
- Scientific DescriptionCCDC98, also known as Abraxas 1, was identified through protein binding studies using the breast and ovarian predisposition protein BRCA1 as the binding target. CCDC98 recruits RAP80, a ubiquitin-binding protein, to BRCA1, allowing the formation of BRCA1 foci in response to DNA damage caused by ionizing radiation. Both CCDC98 and RAP80 are required for DNA damage resistance, G2-M checkpoint control, and DNA repair. Cells depleted of either CCDC98 or RAP80 exhibited increased sensitivity to ionizing radiation, although not as much as in BRCA1-depleted cells, suggesting that CCDC98 and RAP80 control only part of the DNA damage response role of BRCA1. At least two isoforms of CCDC98 are known to exist.
- ReactivityHuman, Mouse
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203